DDW Article Database

Business

VIEW ALL TAGS

Chemistry

VIEW ALL TAGS

Informatics

VIEW ALL TAGS

Personalised Medicine

VIEW ALL TAGS

Screening

VIEW ALL TAGS

LATEST ISSUE: WINTER 2017/18

ARTIFICIAL INTELLIGENCE and biopharma R&D IT

By The PRISME Forum

"R&D productivity remains an ongoing concern. Artificial Intelligence and the accompanying analytics are now so advanced that these tools promise t...

Read More

Bringing IO together: how an immunologist and oncologist collaborate

By Dr Julia Schuler and Dr Louise Brackenbury

For many years, immunology and oncology operated as separate disciplines within drug discovery. However, recent advances in immuno-oncology (IO) ha...

Read More

The Cancer Conundrum increasing clinical success

By Lubna Hussain

Increasing clinical success by implementing improved methodologies in early phase drug discovery. Using primary cells and 3D culture models to enha...

Read More

Driving strategic improvements in biologics drug discovery with scientific informatics

By Dr Andrew LeBeau

Adoption of a scientific informatics system is essential to the success of every drug discovery organisation.

Read More

KINASES - old dogs and new tricks

By Dr Gary Allenby

Application of new assay technologies to shed light on kinase drug discovery.

Read More

How high-throughput CRISPR is set to deliver knockout performance in drug discovery

By Dr Paul Avery and Dr Richard Massey

CRISPR-Cas9 has rapidly transformed our ability to perform targeted gene editing. While the technique has received much interest for its potential ...

Read More

Natural born KILLERS - how natural killer cell therapy will transform immunotherapy

By Dr Azusa Tanaka and Dr Michael Seiler

Regulatory approval of CAR-T cell therapies in 2017 placed the spotlight on immunotherapy approaches that use live cells to attack tumours – a ma...

Read More

Product & Industry News

ADC Bio secures £1.14m investment from Downing LLP

ADC Bio secures £1.14m investment from Downing LLP to finance innovative bioconjugation and US expansion. Funding earmarked for US market pen...

Read More

Cobra Biologics Receives the Queen's Award for Enterprise in International Trade

The prestigious award is in recognition of Cobra’s commercial success in providing services to its global customer base.

Read More

British Breast Cancer Company, Endomag, Wins Queen's Award

Endomag, the surgical guidance company, today announced it has received the Queen’s Award for Enterprise in Innovation for 2018. The Award recogn...

Read More

Helperby Therapeutics Announces Phase 1 Results

Helperby Therapeutics announces phase 1 results demonstrating multiple benefits of its unique combination antibiotic therapy - effective against th...

Read More

Fusion Pharmaceuticals Licenses Isogenica’s CIS Display Technology

Technology will be used to progress Fusion’s pipeline of alpha therapeutics for the treatment of cancers.

Read More

Torque Presents Preclinical Data at AACR

Torque Presents Preclinical Data at AACR Demonstrating that Deep-Primed IL-15 and Deep-Primed IL-12 Anchored to T Cells are Superior to Systemicall...

Read More

Events

ELRIG Discovery Technologies 2018

Dates: 23 May 2018
Venue: Alderley Park, UK

Read More

High-Content and Phenotypic Screening Europe 2018

Dates: 24-25 May 2018
Venue: Cambridge, UK

Read More

Lab-on-a-Chip and Microfluidics Europe 2018

Dates: 5-6 June 2018
Venue: Rotterdam, The Netherlands

Read More

Point-of-Care Diagnostics Europe 2018

Dates: 5-6 June 2018
Venue: Rotterdam, The Netherlands

Read More

Organ-on-a-Chip, Tissue-on-a-Chip Europe 2018

Dates: 5-6 June 2018
Venue: Rotterdam, The Netherlands

Read More